NewAmsterdam Pharma Co N.V. (NAMS) stock
NAMSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NAMSW
$19.74+0.35 (+1.81%)
Close on Nov 18, 2026Market cap $2.36BP/E –Yield –
NewAmsterdam Pharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
NewAmsterdam Pharma's price to book ratio was 3.9× on Nov 11, 2026, against 6.4× a year earlier. Over the last 4 years it ranged from 1.7× to 6.8×, with a median of 3.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.9× | −1.6 |
| 2025 | Dec 31, 2025 | 5.5× | −0.8 |
| 2024 | Dec 31, 2024 | 6.3× | +4.1 |
| 2023 | Dec 29, 2023 | 2.1× | – |
See a number that looks wrong?